Stockreport

Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicine [Read more]